Phlow Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 113

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $30.5M

  • Investors
  • 5

Phlow General Information

Description

Operator of a pharmaceutical company intended to provide low-cost pharmaceuticals and reduce dependency on foreign supply chains. The company's products include precursor chemical ingredients, active healthcare ingredients, and finished pharma products, domestically for essential medicines and to ensure quality, safety, and affordability, enabling practitioners to provide essential medicines to their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 424 Hull Street
  • Suite 400
  • Richmond, VA 23224
  • United States
+1 (804)
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 424 Hull Street
  • Suite 400
  • Richmond, VA 23224
  • United States
+1 (804)

Phlow Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phlow Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 14-Feb-2025 $30.5M Completed Generating Revenue
3. Mezzanine 10-Jul-2024 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Dec-2023 $36M $56M Completed Generating Revenue
1. Early Stage VC (Series A) 16-Feb-2021 $20M $20M Completed Generating Revenue
To view Phlow’s complete valuation and funding history, request access »

Phlow Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-2
Series C-1
Series B-1
Series B
Series A-1 1,000,000 $0.000010 5% $15 $15 1x $15 4.1%
Series A 1,333,333 $0.000010 5% $15 $15 1x $15 5.46%
To view Phlow’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phlow Patents

Phlow Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4583942-A2 Systems and methods for administration of drugs Pending 09-Sep-2022
EP-4583942-A4 Systems and methods for administration of drugs Pending 09-Sep-2022
US-20260021248-A1 Systems and methods for administration of drugs Pending 09-Sep-2022
WO-2024054565-A2 Systems and methods for administration of drugs Inactive 09-Sep-2022
WO-2024054565-A3 Systems and methods for administration of drugs Inactive 09-Sep-2022 A61M5/1422
To view Phlow’s complete patent history, request access »

Phlow Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phlow Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Align Private Capital Asset Manager Minority
Bagel Boy Equity Group Family Office Minority
Virginia Venture Partners Venture Capital Minority
Whole Orange Equity Angel Group Minority
Virginia Innovation Partnership Corporation Not-For-Profit Venture Capital Minority
To view Phlow’s complete investors history, request access »

Phlow FAQs

  • When was Phlow founded?

    Phlow was founded in 2020.

  • Where is Phlow headquartered?

    Phlow is headquartered in Richmond, VA.

  • What is the size of Phlow?

    Phlow has 113 total employees.

  • What industry is Phlow in?

    Phlow’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Phlow a private or public company?

    Phlow is a Private company.

  • What is the current valuation of Phlow?

    The current valuation of Phlow is .

  • What is Phlow’s current revenue?

    The current revenue for Phlow is .

  • How much funding has Phlow raised over time?

    Phlow has raised $91.5M.

  • Who are Phlow’s investors?

    Align Private Capital, Bagel Boy Equity Group, Virginia Venture Partners, Whole Orange Equity, and Virginia Innovation Partnership Corporation have invested in Phlow.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process